Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Income Before Tax
Profit after all operating and non-operating items but before income tax.
Scholar Rock Holding CorporationNASDAQ: SRRK
Income Before Tax · Q3 FY2026 · quarter ended Sep 2026
Income before tax remains negative
Q3 FY2026 income before tax was -$107.24M, compared with -$102.22M a year earlier. Trailing-twelve-month income before tax was -$413.61M.
Context
- Income before tax grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly income before tax holds near -$107.24M or moves back toward the trailing-twelve-month quarterly average of -$103.4M.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Before Tax history
USD · from the income statement
- Latest · FY2025
- (377.94M) USD
- Year-over-year change
- -53.5%
| Period | Period end | Income Before Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (377.94M) | -53.5% |
| FY2024 | 2024-12-31 | (246.29M) | -48.6% |
| FY2023 | 2023-12-31 | (165.79M) | -23.3% |
| FY2022 | 2022-12-31 | (134.5M) | -2.1% |
| FY2021 | 2021-12-31 | (131.8M) | — |
Income Before Tax vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 income before tax of -$413.61M is the 7th highest of the 11 companies compared; the peer median is -$146.79M.
- Its year-over-year change of -17.0% is the 5th highest of 11, against a peer median of -32.2%.
- Income before tax amounts to 72563.2% of revenue for SRRK, versus a peer median of 56.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.16B | +840.9% | — | — | |
| LTM Mar 2026 | $24.47M | +114.9% | — | 1.1% | |
| LTM Jun 2026 | -$67.07M | -110.1% | — | 6.6% | |
| LTM Jun 2026 | -$85.43M | +78.6% | — | 54.7% | |
| LTM Mar 2026 | -$122.54M | -330.7% | — | 612.7% | |
| LTM Mar 2026 | -$171.05M | -431.8% | — | 533.2% | |
| LTM Sep 2026 | -$413.61M | -17.0% | — | 72563.2% | |
| LTM Sep 2026 | -$429.51M | -38.7% | — | — | |
| LTM Jun 2026 | -$519.41M | -25.8% | — | — | |
| LTM Sep 2026 | -$543.8M | -110.2% | — | 56.7% | |
| LTM Jun 2026 | -$706.17M | +9.7% | — | 99.0% | |
| Peer median (excluding SRRK) | -$146.79M | -32.2% | — | 56.7% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 18.82M | 33.19M | 0 | 0 | 0 |
| Cost of Revenue | 108.47M | 123.04M | 2.84M | 1.94M | 208.44M |
| Gross Profit | (89.65M) | (89.85M) | (2.84M) | (1.94M) | (208.44M) |
| Gross Margin | -476.5% | -270.7% | — | — | — |
| Research & Development | 108.47M | 124.44M | 119.06M | 182.61M | 208.44M |
| Selling, General & Admin | 40.27M | 42.62M | 49.4M | 67.5M | 176.21M |
| Operating Expenses | 40.27M | 44.52M | 168.45M | 250.12M | 176.21M |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| EBITDA | (129.17M) | (129.48M) | (162.95M) | (237.52M) | (369.39M) |
| EBITDA Margin | -686.5% | -390.1% | — | — | — |
| Operating Income | (129.92M) | (134.37M) | (171.3M) | (252.05M) | (384.65M) |
| Operating Margin | -690.5% | -404.8% | — | — | — |
| Interest Income | 0 | 0 | 0 | 12.68M | 13.9M |
| Interest Expense | 0 | 0 | 0 | 6.84M | 6.89M |
| Other Income / Expenses | (1.88M) | (132K) | 5.51M | 5.76M | 6.71M |
| Income Before Tax | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Pre-Tax Margin | -700.5% | -405.2% | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Net Margin | -700.5% | -405.2% | — | — | — |
| EPS (Basic) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| EPS (Diluted) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| Weighted Avg Shares | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
| Weighted Avg Shares (Diluted) | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.